The latest upgrades and downgrades for NVIDIA (NVDA) stock, the price target set by the best Wall Street analysts covering the NVIDIA stock.
Bernstein maintains NVIDIA NVDA at Outperform and raises the price target from $130 to $155. (8-29-2024)
DA Davidson maintains NVIDIA at Neutral and maintains a price target of $90. (8-29-2024)
Benchmark reiterates NVIDIA NVDA at Buy and maintains a price target of $170. (8-29-2024)
WestPark Capital maintains NVIDIA at Buy and raises the price target from $127.5 to $165. (8-29-2024)
Morgan Stanley maintains NVIDIA at Overweight and raises the price target from $144 to $150. (8-29-2024)
Craig-Hallum maintains NVIDIA NVDA at Buy and raises the price target from $125 to $165. (8-29-2024)
Wells Fargo maintains NVIDIA NVDA at Overweight and raises the price target from $155 to $165. (8-29-2024)
B of A Securities maintains NVIDIA at Buy and raises the price target from $150 to $165. (8-29-2024)
Baird maintains NVIDIA NVDA at Outperform and raises the price target from $120 to $150. (8-29-2024)
Needham maintains NVIDIA at Buy and raises the price target from $120 to $145. (8-29-2024)
Raymond James maintains NVIDIA at Strong Buy and raises the price target from $120 to $140. (8-29-2024)
Mizuho maintains NVIDIA at Outperform and raises the price target from $132 to $140. (8-29-2024)
Truist Securities maintains NVDA at Buy and raises the price target from $140 to $145. (8-27-2024)
Loop Capital reiterates NVIDIA NVDA at Buy and maintains a price target of $175. (8-26-2024)
Wedbush maintains NVIDIA NVDA at Outperform and raises the price target from $120 to $138. (8-23-2024)
Evercore ISI Group maintains NVIDIA NVDA at Outperform and raises the price target from $145 to $150. (8-23-2024)
Goldman Sachs reiterates NVIDIA $NVDA at Buy and maintains a price target of $135. (8-19-2024)
New Street Research upgrades NVIDIA from Neutral to Buy and announces a price target of $120. (8-9-2024)
Deutsche Bank maintains NVIDIA NVDA at Hold and maintains a price target of $100. (8-5-2024)
Goldman Sachs maintains NVIDIA at Buy and maintains a price target of $135. (8-5-2024)
Loop Capital maintains NVIDIA at Buy and raises the price target from $120 to $175. (7-22-2024)
Piper Sandler maintains NVIDIA at Overweight and raises the price target from $120 to $140. (7-22-2024)
TD Cowen maintains NVIDIA NVDA at Buy and raises the price target from $140 to $165. (7-15-2024)
Benchmark maintains NVIDIA at Buy and raises the price target from $135 to $170. (7-12-2024)
Keybanc maintains NVIDIA NVDA at Overweight and raises the price target from $130 to $180. (7-9-2024)
UBS maintains NVIDIA NVDA at Buy and raises the price target from $120 to $150. (7-8-2024)
New Street Research downgrades NVIDIA from Buy to Neutral. (7-5-2024)
Morgan Stanley maintains NVIDIA NVDA at Overweight and raises the price target from $116 to $144. (7-1-2024)
Truist Securities reiterates NVIDIA NVDA at Buy and raises the price target from $128.8 to $140. (6-27-2024)
Cantor Fitzgerald maintains NVIDIA NVDA at Overweight and raises the price target from $140 to $. 175. (6-26-2024)
Citigroup maintains NVIDIA NVDA at Buy and raises the price target from $126 to $150. (6-26-2024)
Jefferies maintains NVIDIA at Buy and raises the price target from $135 to $150. (6-24-2024)
Melius Research maintains NVIDIA NVDA at Buy and raises the price target from $125 to $160. (6-21-2024)
Wells Fargo maintains NVIDIA at Overweight and raises the price target from $125 to $155. (6-18-2024)
Evercore ISI Group maintains NVIDIA at Outperform and raises the price target from $131 to $145. (6-11-2024)
Goldman Sachs maintains NVIDIA at Buy and raises the price target from $120 to $135. (6-11-2024)
Morgan Stanley maintains NVIDIA at Overweight and adjusts price target to $116. (6-10-2024)
Barclays maintains NVIDIA at Overweight, adjustsprice target from $1200 to $145. (6-10-2024)
Susquehanna maintains NVIDIA NVDA at Positive and raises the price target from $1200 to $145. (6-10-2024)
Mizuho maintains NVIDIA NVDA at Buy and raises the price target from $1180 to $1275. (6-4-2024)
Cantor Fitzgerald maintains NVIDIA at Overweight and raises the price target from $1200 to $1400. (5-23-2024)
TD Cowen maintains NVIDIA at Buy and raises the price target from $1100 to $1200. (5-23-2024)
Wedbush maintains NVIDIA at Outperform and raises the price target from $1000 to $1200. (5-23-2024)
Craig-Hallum maintains NVIDIA at Buy and raises the price target from $850 to $1250. (5-23-2024)
Deutsche Bank maintains NVIDIA NVDA at Hold and raises the price target from $850 to $1000. (5-23-2024)
Citigroup maintains NVIDIA at Buy and raises the price target from $1030 to $1260. (5-23-2024)
Wells Fargo maintains NVIDIA at Overweight and raises the price target from $1150 to $1250. (5-23-2024)
Benchmark maintains NVIDIA NVDA at Buy and raises the price target from $1000 to $1350. (5-23-2024)
Oppenheimer reiterates NVIDIA NVDA at Outperform and maintains a price target of $1100. (5-23-2024)
Truist Securities maintains NVIDIA at Buy and raises the price target from $1177 to $1288. (5-23-2024)
Barclays maintains NVIDIA NVDA at Overweight and raises the price target from $1100 to $1200. (5-23-2024)
JP Morgan maintains NVIDIA NVDA at Overweight and raises the price target from $850 to $1150. (5-23-2024)
Susquehanna maintains NVIDIA NVDA at Positive and raises the price target from $1100 to $1200. (5-23-2024)
Bernstein maintains NVIDIA NVDA at Outperform and raises the price target from $1000 to $1300. (5-23-2024)
Stifel maintains NVIDIA NVDA at Buy and raises the price target from $1085 to $1140. (5-23-2024)
Piper Sandler maintains NVIDIA NVDA at Overweight and raises the price target from $1050 to $1200. (5-23-2024)
Mizuho maintains NVIDIA NVDA at Buy raising the price target from $1000 to $1180. (5-23-2024)
Evercore ISI Group maintains NVIDIA at Outperform and raises the price target from $1160 to $1310. (5-23-2024)
B of A Securities maintains NVIDIA NVDA at Buy and raises the price target from $1100 to $1320. (5-23-2024)
Needham maintains NVDA at Buy and raises the price target from $850 to $1200. (5-23-2024)
Goldman Sachs maintains NVIDIA at Buy and raises the price target from $1100 to $1200. (5-23-2024)
Wolfe Research maintains NVIDIA at Outperform and raises the price target from $1200 to $1250. (5-23-2024)
Barclays maintains NVIDIA at Overweight and raises the price target from $850 to $1100. (5-20-2024)
Susquehanna maintains NVIDIA at Positive and raises the price target from $1050 to $1100. (5-20-2024)
Stifel maintains NVIDIA NVDA at Buy and raises the price target from $910 to $1085. (5-20-2024)
Baird maintains NVDA at Outperform and raises the price target from $1050 to $1200. (5-20-2024)
Oppenheimer reiterates NVDA at Outperform and maintains a price target of $1100. (5-17-2024)
Wedbush reiterates NVDA at Outperform and maintains a price target of $1000. (5-16-2024)
Wells Fargo maintains NVIDIA NVDA at Overweight and raises the price target from $970 to $1150. (5-14-2024)
Jefferies assumes NVDA at Buy rating and raises Price Target to $1200. (5-13-2024)
HSBC maintains NVIDIA at Buy and raises the price target from $1050 to $1350. (5-10-2024)
Goldman Sachs maintains NVIDIA at Buy and raises the price target from $1000 to $1100. (5-7-2024)
UBS maintains NVDA at Buy and raises the price target from $1100 to $1150. (4-30-2024)
Evercore ISI Group initiates coverage on NVIDIA NVDA at Outperform rating and a price target of $1160. (4-16-2024)
Raymond James maintains NVDA at Strong Buy and raises the price target from $850 to $1100. (4-11-2024)
Keybanc maintains NVIDIA at Overweight and raises the price target from $1100 to $1200. (4-8-2024)
Susquehanna maintains NVDA at Positive and maintains a price target of $1050. (4-4-2024)
TD Cowen maintains NVIDIA at Outperform and raises the price target from $900 to $1100. (3-21-2024)
Stifel reiterates NVDA at Buy and maintains a price target of $910. (3-21-2024)
Argus Research maintains NVIDIA NVDA at Buy and raises the price target from $850 to $950. (3-20-2024)
Deutsche Bank maintains NVDA at Hold and raises the price target from $720 to $850. (3-20-2024)
Goldman Sachs maintains NVIDIA NVDA at Buy and raises the price target from $875 to $1000. (3-20-2024)
Benchmark reiterates NVDA at Buy and maintains a price target of $1000. (3-20-2024)
Citigroup maintains NVIDIA NVDA at Buy and raises the price target from $820 to $1030. (3-20-2024)
Piper Sandler maintains NVDA at Overweight and raises the price target from $850 to $1050. (3-20-2024)
Oppenheimer maintains NVDA at Outperform and raises the price target from $850 to $1100. (3-20-2024)
Keybanc maintains NVIDIA NVDA at Overweight and maintains a price target of $1100. (3-19-2024)
Wedbush reiterates NVDA at Outperform and maintains a price target of $1000. (3-19-2024)
Susquehanna maintains NVIDIA at Positive and raises the price target from $850 to $1050. (3-19-2024)
Wells Fargo maintains NVDA at Overweight and raises the price target from $840 to $970. (3-19-2024)
Truist Securities maintains NVIDIA NVDA at Buy and raises the price target from $911 to $1177. (3-18-2024)
HSBC maintains NVIDIA at Buy and raises the price target from $880 to $1050. (3-18-2024)
B of A Securities maintains NVDA at Buy and raises the price target from $925 to $1100. (3-13-2024)
Cantor Fitzgerald maintains NVDA at Overweight and raises the price target from $900 to $1200. (3-8-2024)
CICC initiates coverage on NVIDIA at Outperform rating and a price target of $870. (3-6-2024)
Cantor Fitzgerald reiterates NVIDIA NVDA at Overweight and maintains a price target of $900. (3-4-2024)
Tigress Financial maintains NVIDIA NVDA at Buy and raises the price target from $790 to $985. (2-29-2024)
Wedbush maintains NVDA at Outperform and raises the price target from $800 to $850. (2-22-2024)
Cantor Fitzgerald reiterates NVDA at Overweight and maintains a price target of $775. (2-20-2024)
Wedbush maintains NVDA at Outperform and raises the price target from $600 to $800. (2-16-2024)
Loop Capital initiates coverage on NVDA at Buy rating and a price target of $1200, (2-16-2024)
Mizuho maintains NVDA at Buy and raises the price target from $625 to $825. (2-13-2024)
Cantor Fitzgerald reiterates NVDA at Overweight and maintains a price target of $775. (2-12-2024)
Goldman Sachs maintains NVDA at Buy and raises the price target from $625 to $800. (2-5-2024)
Cantor Fitzgerald reiterates NVDA at Overweight and maintains a price target of $775. (1-29-2024)
Cantor Fitzgerald initiates coverage on NVDA at Overweight rating and a price target of $775. (1-23-2024)
Raymond James maintains NVDA at Strong Buy and raises the price target from $600 to $700. (1-19-2024)
Tigress Financial maintains NVDA at Buy and raises the price target from $560 to $790. (1-18-2024)
Keybanc maintains NVDA at Overweight and raises the price target from $650 to $740. (1-16-2024)
DA Davidson initiates coverage on NVDA at a Neutral rating and set a Price Target of $410. (1-10-2024)
UBS maintains NVDA at Buy and raises the price target from $560 to $580. (11-22-2023)
Susquehanna reiterates NVDA at Positive and maintains a price target of $625. (11-22-2023)
Stifel maintains NVDA at Buy and raises the price target from $600 to $665. (11-22-2023)
Oppenheimer reiterates NVDA at Outperform and maintains a price target of $650. (11-22-2023)
Mizuho maintains NVDA at Buy and raises the price target from $590 to $625. (11-22-2023)
Benchmark reiterates NVDA at Buy and maintains a price target of $625. (11-22-2023)
BMO Capital maintains NVDA at Outperform and raises the price target from $600 to $650. (11-22-2023)
Wedbush reiterates NVDA at Outperform and maintains a price target of $600. (11-22-2023)
Morgan Stanley maintains NVDA at Overweight and raises the price target from $600 to $603. (11-22-2023)
Needham reiterates NVDA at Buy and maintains a price target of $600. (11-22-2023)
Stifel reiterates NVDA at Buy and maintains a price target of $600. (11-17-2023)
Wedbush reiterates NVDA at Outperform and maintains a price target of $600. (11-17-2023)
Bernstein reiterates NVDA at Outperform and maintains a price target of $675. (11-9-2023)
Keybanc maintains NVDA at Overweight and cuts the price target from $750 to $650. (10-20-2023)
Keybanc maintains NVDA at Overweight and raises the price target from $670 to $750. (10-3-2023)
Argus Research maintains NVDA at Buy and raises the price target from $450 to $600. (8-24-2023)
Benchmark maintains NVDA at Buy and raises the price target from $475 to $625. (8-24-2023)
Wedbush maintains NVDA at Outperform and raises the price target from $490 to $600. (8-24-2023)
UBS maintains NVDA at Buy and raises the price target from $540 to $560. (8-24-2023)
Baird maintains NVDA at Outperform and raises the price target from $570 to $750. (8-24-2023)
Wells Fargo maintains NVDA at Overweight and raises the price target from $500 to $600. (8-24-2023)
Susquehanna maintains NVDA at Positive and raises the price target from $575 to $600. (8-24-2023)
TD Cowen maintains NVDA at Outperform and raises the price target from $500 to $600. (8-24-2023)
Deutsche Bank maintains NVDA at Hold and raises the price target from $440 to $560. (8-24-2023)
WestPark Capital upgrades NVDA from Hold to Buy and a price target of $690. (8-24-2023)
Stifel upgrades NVDA from Hold to Buy and raises the price target from $440 to $600. (8-24-2023)
Exane BNP Paribas upgrades NVDA from Neutral to Outperform and set a price target of $745. (8-24-2023)
Keybanc maintains NVDA at Overweight and raises the price target from $620 to $670. (8-24-2023)
BMO Capital maintains NVDA at Outperform and raises the price target from $450 to $550. (8-21-2023)
HSBC maintains NVDA at Buy and raises the price target from $600 to $780. (8-21-2023)
Keybanc maintains NVDA at Overweight and raises the price target from $550 to $620. (8-21-2023)
Oppenheimer maintains NVDA at Outperform and raises the price target from $420 to $500. (8-17-2023)
Baird maintains NVDA at Outperform and raises the price target from $475 to $570. (8-15-2023)
Wells Fargo maintains NVDA at Overweight and raises the price target from $450 to $500. (8-15-2023)
UBS maintains NVDA at Buy and raises the price target from $475 to $540. (8-15-2023)
Barclays maintains NVDA at Overweight and raises the price target from $500 to $600. (7-20-2023)
Wolfe Research initiates coverage on NVDA at Outperform rating and a price target of $570. (7-20-2023)
Keybanc maintains NVDA at Overweight and raises the price target from $500 to $550. (7-11-2023)
Goldman Sachs maintains NVDA at Buy and raises the price target from $440 to $495. (7-10-2023)
Tigress Financial maintains NVDA at Buy and raises the price target from $320 to $560. (7-7-2023)
Daiwa Capital upgrades NVDA from Neutral to Outperform and raises the price target from $408 to $475. (6-30-2023)
Morgan Stanley maintains NVDA at Overweight and raises the price target from $450 to $500. (6-16-2023)
B of A Securities maintains NVDA at Buy and raises the price target from $450 to $500. (5-31-2023)
Stifel maintains NVDA at Hold and raises the price target from $300 to $370. (5-25-2023)
BMO Capital maintains NVDA at Cautious and raises the price target from $350 to $450. (5-25-2023)
UBS maintains NVDA at Buy and raises the price target from $315 to $475. (5-25-2023)
Piper Sandler maintains NVDA at Overweight and raises the price target from $300 to $440. (5-25-2023)
Deutsche Bank maintains NVDA with a Hold and raises the price target from $220 to $390. (5-25-2023)
Mizuho maintains NVDA at Buy and raises the price target from $290 to $400. (5-25-2023)
Raymond James maintains NVIDIA at Strong Buy and raises the price target from $290 to $450. (5-25-2023)
JP Morgan maintains NVDA at Overweight and raises the price target from $250 to $500. (5-25-2023)
Wells Fargo maintains NVDA at Overweight and raises the price target from $320 to $450. (5-25-2023)
Susquehanna maintains NVDA at Positive and raises the price target from $350 to $450. (5-25-2023)
Oppenheimer maintains NVDA at Outperform and raises the price target from $350 to $420. (5-25-2023)
Needham maintains NVDA at Buy and raises the price target from $300 to $460. (5-25-2023)
Goldman Sachs maintains NVDA at Buy and raises the price target from $275 to $440. (5-25-2023)
Barclays maintains NVDA at Overweight and raises the price target from $275 to $500. (5-25-2023)
Read also: Nvidia NVDA Q1 Earnings for 2024 Beat Expectations
Bernstein maintains NVDA at Outperform and raises the price target from $300 to $475. (5-25-2023)
Keybanc maintains NVDA at Overweight and raises the price target from $375 to $500. (5-25-2023)
Citigroup maintains NVDA at Buy and raises the price target from $305 to $363. (5-24-2023)
Wedbush maintains NVDA at Neutral and raises the price target from $216 to $290. (5-22-2023)
Keybanc maintains NVDA at Overweight and raises the price target from $320 to $375. (5-22-2023)
Oppenheimer maintains NVDA at Outperform and raises the price target from $300 to $350. (5-18-2023)
B of A Securities maintains NVDA at Buy and raises the price target from $310 to $340. (4-19-2023)
HSBC analyst Frank Lee upgrades NVDA from Reduce to Buy and raises the price target from $175 to $355. (4-18-2023)
Keybanc maintains NVDA at Overweight and raises the price target from $280 to $320. (4-11-2023)
Bernstein Maintains Outperform on NVDA and raises the Price Target to $300. (3-29-2023)
UBS Reiterated NVDA at Buy and raised the price target from $270 to $315. (3-27-2023)
Needham maintains NVDA at Buy and raises the price target from $270 to $300. (3-23-2023)
Deutsche Bank maintains NVDA at Hold and raises the price target from $200 to $220. (3-22-2023)
BMO Capital maintains NVDA at Outperform and raises the price target from $255 to $305. (3-22-2023)
Exane BNP Paribas upgrades NVDA from Underperform to Neutral and a price target of $230. (3-21-2023)
Morgan Stanley upgrades NVDA from Equal-Weight to Overweight and raises the price target from $255 to $304. (3-17-2023)
Susquehanna reiterates NVDA at Positive and a price target of $265. (3-9-2023)
Raymond James assumes NVDA at a Strong Buy and a price target of $290. (3-2-2023)
Wells Fargo maintains NVDA at Overweight and raises the price target from $250 to $275. (2-23-2023)
Goldman Upgraded NVDA from Neutral to Buy and raised the price target from $162 to $275. (2-23-2023)
Craig-Hallum maintains NVDA at Hold and raises the price target from $165 to $190. (2-23-2023)
Deutsche Bank maintains NVDA at Hold and raises the price target from $170 to $200. (2-23-2023)
Citigroup maintains NVDA at Buy and raises the price target from $210 to $245. (2-23-2023)
Needham maintains NVDA at Buy and raises the price target from $230 to $270. (2-23-2023)
Piper Sandler maintains NVDA at Overweight and raises the price target from $200 to $225. (2-21-2023)
Morgan Stanley maintains NVDA at Equal-Weight and raises the price target from $175 to $246. (2-21-2023)
Oppenheimer maintains NVDA at Outperform and raises the price target from $225 to $250. (2-21-2023)
BMO Capital maintains NVDA at Outperform and raises the price target from $210 to $240. (2-21-2023)
Keybanc maintains NVDA at Overweight and raises the price target from $220 to $280. (2-16-2023)
DZ Bank downgrades NVDA from Buy to Sell and a price target of $195. (2-16-2023)
Barclays maintains NVDA at Overweight and raises the price target from $170 to $250. (1-23-2023)
Keybanc maintains NVDA at Overweight and cuts the price target from $230 to $220. (1-11-2023)
Needham maintains NVDA at Buy and raises the price target from $200 to $230. (12-19-2022)
Stifel maintains NVDA at Hold and raises the price target from $165 to $175. (11-17-2022)
Morgan Stanley maintains NVDA at Equal-Weight and cuts the price target from $182 to $175. (11-17-2022)
Stocks, Crypto, Forex and Commodities Breaking News. The latest news and analysis on metals, energy, and agriculture. Live news about gold, silver, copper, platinum, natural gas, crude oil, wheat, soybeans, rice coffee, sugar, cocoa, lumber and cotton.
